Vicki L Goodman is EVP, Prod Dev & Med Aff &CMO of EXELIXIS, INC.. Currently has a direct ownership of 307,654 shares of EXEL, which is worth approximately $11 Million. The most recent transaction as insider was on Apr 03, 2023, when has been sold 82,566 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 308K
0% 3M change
0% 12M change
Total Value Held $11 Million

Vicki L Goodman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2023
BUY
Grant, award, or other acquisition
-
82,566 Added 21.16%
307,654 Common Stock
Feb 15 2023
SELL
Payment of exercise price or tax liability
$312,765 $18.08 p/Share
17,299 Reduced 7.14%
225,088 Common Stock
Jan 04 2022
SELL
Payment of exercise price or tax liability
$146,017 $19.18 p/Share
7,613 Reduced 3.05%
242,387 Common Stock
Jan 04 2022
BUY
Grant, award, or other acquisition
-
250,000 Added 50.0%
250,000 Common Stock

Also insider at

MURA
Mural Oncology plc
VLG

Vicki L Goodman

EVP, Prod Dev & Med Aff &CMO
Alameda, CA

Track Institutional and Insider Activities on EXEL

Follow EXELIXIS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXEL shares.

Notify only if

Insider Trading

Get notified when an Exelixis, Inc. insider buys or sells EXEL shares.

Notify only if

News

Receive news related to EXELIXIS, INC.

Track Activities on EXEL